We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
5 Value Picks Amid AI-Driven Tech Selloff & U.S.-Iran Tension
Major U.S. stock market indices slipped on Feb. 3, as a tech sell-off rippled through Wall Street. Software stocks, already under pressure, took another hit after AI startup Anthropic rolled out new workplace tools, reigniting fears that artificial intelligence may replace—not just support—traditional software models.
At the same time, geopolitics added to the unease. Renewed U.S.-Iran tensions, including reports of a U.S. carrier shooting down an Iranian drone, added another layer of geopolitical risk. In this environment of relatively high rates, tech disruption and global uncertainty, fundamentals matter—making value investing harder to ignore.
Harmony Biosciences Holdings Inc., Adecoagro S.A., Sociedad Quimica y Minera de Chile S.A., Angi, Inc. and PHINIA Inc. are a few solid high earnings yield picks for value investors.
Unlocking Value with Earnings Yield Metric
Value investing is a time-tested strategy that focuses on finding assets trading for less than their intrinsic value, allowing investors to buy such undervalued assets at a discount. This approach hinges on the idea that market prices often don't fully reflect a company's fundamentals, providing opportunities to benefit from market corrections in the long run.
A key metric for value investors is earnings yield, which offers insight into a stock's profitability relative to its market price. Earnings yield is calculated by dividing a company's earnings per share (EPS) by its current stock price (Earnings Yield = EPS/Current Stock Price). This figure represents the profit generated for each dollar invested, effectively serving as the inverse of the price-to-earnings (P/E) ratio. A higher earnings yield typically indicates that a stock may be undervalued and could provide growth potential, while a lower earnings yield could suggest overvaluation.
Beyond identifying individual stocks, earnings yield also aids in comparing the stock market to fixed-income investments, like 10-year Treasury bonds. If the earnings yield of a market index surpasses the bond yield, it can indicate favorable conditions for investing in stocks over bonds, which is valuable for portfolio diversification.
Our Picks
Here we highlight five of the 53 stocks that qualified the screening:
Harmony Biosciences is a pharmaceutical company engaged in developing and commercializing therapies for rare neurological disorders.The Zacks Consensus Estimate for HRMY's 2026 sales and earnings implies year-over-year growth of 17% and 27%, respectively. EPS estimates for the current year have moved up by 28 cents over the past 30 days. Harmony Biosciences currently sports a Zacks Rank #1 and has a Value Score of A.
Adecoagro is an agricultural company engaged in farming crops and other agricultural products, cattle and dairy operations, sugar, ethanol and energy production and land transformation. The Zacks Consensus Estimate for AGRO's 2026 sales and earnings implies year-over-year growth of 30% and 452%, respectively. EPS estimates for the current year have moved up by 43 cents over the past 30 days. Adecoagro currently sports a Zacks Rank #1 and has a Value Score of A.
Sociedad Quimica produces and distributes specialty plant nutrients and fertilizers, lithium derivatives and industrial chemicals.The Zacks Consensus Estimate for SQM's 2026 sales and earnings implies year-over-year growth of 55% and 181%, respectively. EPS estimates for the current year have moved up by $1.55 over the past seven days. Sociedad Quimica currently sports a Zacks Rank #1 and has a Value Score of B.
Angi operates a digital marketplace that connects homeowners with skilled service professionals, reflecting the expanding reach of the gig economy into essential home services. The Zacks Consensus Estimate for ANGI's 2026 sales and earnings implies year-over-year growth of 3% and 36%, respectively. EPS estimates for the current year have moved up by 16 cents over the past 30 days. Angi currently sports a Zacks Rank #1 and has a Value Score of A.
PHINIA, headquartered in Michigan, is a leader in premium fuel systems, electrical systems, and aftermarket solutions for the automotive industry.The Zacks Consensus Estimate for PHIN's 2026 sales and earnings implies year-over-year growth of 2% and 15%, respectively. EPS estimates for 2026 have moved up by 66 cents over the past 60 days. PHINIA currently sports a Zacks Rank #1 and has a Value Score of A.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Zacks.com featured highlights include Harmony Biosciences, Adecoagro, Sociedad Quimica y Minera de Chile, Angi and PHINIA
For Immediate Release
Chicago, IL – February 5, 2026 – Stocks in this week’s article are Harmony Biosciences Holdings Inc. (HRMY - Free Report) , Adecoagro S.A. (AGRO - Free Report) , Sociedad Quimica y Minera de Chile S.A. (SQM - Free Report) , Angi, Inc. (ANGI - Free Report) and PHINIA Inc. (PHIN - Free Report) .
5 Value Picks Amid AI-Driven Tech Selloff & U.S.-Iran Tension
Major U.S. stock market indices slipped on Feb. 3, as a tech sell-off rippled through Wall Street. Software stocks, already under pressure, took another hit after AI startup Anthropic rolled out new workplace tools, reigniting fears that artificial intelligence may replace—not just support—traditional software models.
At the same time, geopolitics added to the unease. Renewed U.S.-Iran tensions, including reports of a U.S. carrier shooting down an Iranian drone, added another layer of geopolitical risk. In this environment of relatively high rates, tech disruption and global uncertainty, fundamentals matter—making value investing harder to ignore.
Harmony Biosciences Holdings Inc., Adecoagro S.A., Sociedad Quimica y Minera de Chile S.A., Angi, Inc. and PHINIA Inc. are a few solid high earnings yield picks for value investors.
Unlocking Value with Earnings Yield Metric
Value investing is a time-tested strategy that focuses on finding assets trading for less than their intrinsic value, allowing investors to buy such undervalued assets at a discount. This approach hinges on the idea that market prices often don't fully reflect a company's fundamentals, providing opportunities to benefit from market corrections in the long run.
A key metric for value investors is earnings yield, which offers insight into a stock's profitability relative to its market price. Earnings yield is calculated by dividing a company's earnings per share (EPS) by its current stock price (Earnings Yield = EPS/Current Stock Price). This figure represents the profit generated for each dollar invested, effectively serving as the inverse of the price-to-earnings (P/E) ratio. A higher earnings yield typically indicates that a stock may be undervalued and could provide growth potential, while a lower earnings yield could suggest overvaluation.
Beyond identifying individual stocks, earnings yield also aids in comparing the stock market to fixed-income investments, like 10-year Treasury bonds. If the earnings yield of a market index surpasses the bond yield, it can indicate favorable conditions for investing in stocks over bonds, which is valuable for portfolio diversification.
Our Picks
Here we highlight five of the 53 stocks that qualified the screening:
Harmony Biosciences is a pharmaceutical company engaged in developing and commercializing therapies for rare neurological disorders.The Zacks Consensus Estimate for HRMY's 2026 sales and earnings implies year-over-year growth of 17% and 27%, respectively. EPS estimates for the current year have moved up by 28 cents over the past 30 days. Harmony Biosciences currently sports a Zacks Rank #1 and has a Value Score of A.
Adecoagro is an agricultural company engaged in farming crops and other agricultural products, cattle and dairy operations, sugar, ethanol and energy production and land transformation. The Zacks Consensus Estimate for AGRO's 2026 sales and earnings implies year-over-year growth of 30% and 452%, respectively. EPS estimates for the current year have moved up by 43 cents over the past 30 days. Adecoagro currently sports a Zacks Rank #1 and has a Value Score of A.
Sociedad Quimica produces and distributes specialty plant nutrients and fertilizers, lithium derivatives and industrial chemicals.The Zacks Consensus Estimate for SQM's 2026 sales and earnings implies year-over-year growth of 55% and 181%, respectively. EPS estimates for the current year have moved up by $1.55 over the past seven days. Sociedad Quimica currently sports a Zacks Rank #1 and has a Value Score of B.
Angi operates a digital marketplace that connects homeowners with skilled service professionals, reflecting the expanding reach of the gig economy into essential home services. The Zacks Consensus Estimate for ANGI's 2026 sales and earnings implies year-over-year growth of 3% and 36%, respectively. EPS estimates for the current year have moved up by 16 cents over the past 30 days. Angi currently sports a Zacks Rank #1 and has a Value Score of A.
PHINIA, headquartered in Michigan, is a leader in premium fuel systems, electrical systems, and aftermarket solutions for the automotive industry.The Zacks Consensus Estimate for PHIN's 2026 sales and earnings implies year-over-year growth of 2% and 15%, respectively. EPS estimates for 2026 have moved up by 66 cents over the past 60 days. PHINIA currently sports a Zacks Rank #1 and has a Value Score of A.
Why Haven't You Looked at Zacks' Top Stocks?
Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.
Today you can access their live picks without cost or obligation.
See Stocks Free >>
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2828864/5-value-picks-amid-ai-driven-tech-sell-off-us-iran-tensions
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
About Screen of the Week
Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.